Action Intercure - INCR.U

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

1,53

Prix Achat

1,47

Prix Vente

1,64

Volume échangé

0,00 Fourchette du Jour 0,00

1,53 Plage de 52 semaines 1,53

Cap du marché

69,727M

Clôture Veille

1,53

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

Actions en circulation

45 573 000

Rendement du Dividende

Ratio Cours sur Bénéfices

-1,13

Bénéfice par action (BPA)

-1,36

Chiffre d'affairess

355,55M

Bénéfice net

-61,96M

Secteur

Pharmaceutical Preparations

Industrie

Medical Eq Rental & Leasing

Site Web

www.intercure.co

Siège social

Herzliya, Center, Isr

Fondé

2021

Intercure Ltd est coté dans le secteur Pharmaceutical Preparations de la Toronto Stock Exchange avec le ticker INCR.U. Le dernier cours de clôture d'Intercure était de US$1,53. Au cours de la dernière année, les actions de Intercure ont été négociées dans une fourchette de prix de US$ 1,53 à US$ 1,53.

Intercure compte actuellement 45 573 000 actions en circulation. La capitalisation boursière d'Intercure est de US$69,73 million. Intercure a un ratio cours/bénéfice (ratio PE) de -1.13.

InterCure Provides an Update Regarding the Security Situation in Israel

NEW YORK, and HERZLIYA, Israel, Oct. 17, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR...

InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY

Achieved record revenues of NIS 209 million ($75 million)1 for the first half of 2023 Annualized revenue run...

InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE

NEW YORK and TORONTO and HERZLIYA, Israel, July 10, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR...

InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

NEW YORK and TORONTO and HERZLIYA, Israel, June 09, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR...

InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference

NEW YORK, TORONTO, and HERZLIYA, Israel, May 15, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX:...

InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY

Achieved record revenues of $40 million for the first quarter Annualized revenue run rate of $159 million...

InterCure to Be Featured with Mike Tyson in an Exclusive Interview on Fox Business

NEW YORK and TORONTO and HERZLIYA, Israel, May 15, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: INCR) (TSX: INCR.U...

InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary

NEW YORK and TORONTO and HERZLIYA, Israel, April 25, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR...

InterCure Informs That An Application To Approve a Class Action Against 26 Cannabis Companies in Israel, Including InterCure, Was Filed to The Court In Israel

NEW YORK, TORONTO, and HERZLIYA, Israel, April 24, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR...

InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries

NEW YORK and TORONTO and HERZLIYA, Israel, April 20, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ:...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	1.53	1.53	1.53	0	0	CS
4	0	0	1.53	1.53	1.53	0	0	CS
12	0	0	1.53	1.53	1.53	0	0	CS
26	0	0	1.53	1.53	1.53	0	0	CS
52	0	0	1.53	1.53	1.53	0	0	CS
156	-5.22	-77.3333333333	6.75	7.5	1.47	350	5.89676254	CS
260	-7.47	-83	9	9.78	1.47	4021	6.94760878	CS

INCR.U - Frequently Asked Questions (FAQ)

What is the current Intercure share price?

The current share price of Intercure is US$ 1,53

How many Intercure shares are in issue?

Intercure has 45 573 000 shares in issue

What is the market cap of Intercure?

The market capitalisation of Intercure is USD 69,73M

What is the 1 year trading range for Intercure share price?

Intercure has traded in the range of US$ 1,53 to US$ 1,53 during the past year

What is the PE ratio of Intercure?

The price to earnings ratio of Intercure is -1,13

What is the cash to sales ratio of Intercure?

The cash to sales ratio of Intercure is 0,2

What is the reporting currency for Intercure?

Intercure reports financial results in ILS

What is the latest annual turnover for Intercure?

The latest annual turnover of Intercure is ILS 355,55M

What is the latest annual profit for Intercure?

The latest annual profit of Intercure is ILS -61,96M

What is the registered address of Intercure?

The registered address for Intercure is 85 MEDINAT HA-YEHUDIM STREET, HERZLIYA, CENTER, 4676670

What is the Intercure website address?

The website address for Intercure is www.intercure.co

Which industry sector does Intercure operate in?

Intercure operates in the MEDICAL EQ RENTAL & LEASING sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
LCFSTidewater Renewables Ltd	$ 1,72 (173,02%)	1,04M
TWMTidewater Midstream and Infrastructure Ltd	$ 0,20 (66,67%)	6,93M
GMTNGold Mountain Mining Corp	$ 0,025 (25,00%)	20k
FLNTFlint Corporation	$ 0,03 (20,00%)	47,02k
WLLWWillow Biosciences Inc	$ 0,04 (14,29%)	46k
BNGBengal Energy Ltd	$ 0,01 (-33,33%)	3k
VRTSVertiqal Studios Corporation	$ 0,02 (-20,00%)	2k
MSVMinco Silver Corp	$ 0,185 (-17,78%)	188,81k
DCBODocebo Inc	$ 46,42 (-13,80%)	385,69k
SLT.USaltire Capital Ltd	US$ 4,25 (-11,83%)	2,17k
MEGMEG Energy Corp	$ 22,54 (-1,79%)	19,52M
ENBEnbridge Inc	$ 61,81 (2,56%)	17,09M
CNQCanadian Natural Resources Ltd	$ 40,85 (0,12%)	16,17M
PKIParkland Corporation	$ 35,61 (-2,20%)	15,72M
VRNVeren Inc	$ 7,91 (4,49%)	9,79M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Intercure Ltd (INCR.U)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Intercure Ltd

INCR.U Dernières nouvelles

InterCure Provides an Update Regarding the Security Situation in Israel

InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY

InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE

InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference

InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY

InterCure to Be Featured with Mike Tyson in an Exclusive Interview on Fox Business

InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary

InterCure Informs That An Application To Approve a Class Action Against 26 Cannabis Companies in Israel, Including InterCure, Was Filed to The Court In Israel

InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries

INCR.U - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Intercure Ltd (INCR.U) Cours

Intercure Ltd (INCR.U)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Intercure Ltd

INCR.U Dernières nouvelles

InterCure Provides an Update Regarding the Security Situation in Israel

InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY

InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE

InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference

InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY

InterCure to Be Featured with Mike Tyson in an Exclusive Interview on Fox Business

InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary

InterCure Informs That An Application To Approve a Class Action Against 26 Cannabis Companies in Israel, Including InterCure, Was Filed to The Court In Israel

InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries

INCR.U - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités